Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maintenance Azacitidine in Elderly AML
NCT00387647Phase 2Completed
- Sponsor
- Moffitt Cancer Center
- Start
- Aug 2006
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azacitidine in acute myeloid leukemia (AML), sponsored by Moffitt Cancer Center. Started Aug 2006; status: completed.
02
Drugs
azacitidine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00387647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00387647.